Paul Hastings Advised Organovo Holdings On Sale Of FXR Program To Eli Lilly Paul Hastings LLP advised Organovo Holdings, Inc. (Nasdaq: ONVO), a clinical-stage biotechnology company specializing in...
Covington Advised AstraZeneca On Acquisition Of EsoBiotec Covington advised AstraZeneca on its definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell therapies...
Skadden And Latham & Watkins Advised On Otsuka Pharmaceutical's $1.12 Billion Acquisition Of Jnana Therapeutics Otsuka Pharmaceutical acquired Boston-based biotechnology firm Jnana Therapeutics...
Juris Prime Advised Consortium Of Lenders In Project Finance Deal For Laurus Labs Juris Prime, has assisted the consortium of Lenders in respect of Project Finance transaction for Laurus Labs...
Pfizer Emerges Victorious, Secures $107.5 Million from AstraZeneca in US Cancer Drug Patent Trial AstraZeneca has been ordered to pay $107.5 million in damages to Pfizer. The jury found that...
Covington Advised MultiplAI Health On $340M Merger With OmnigenicsAI And APx Covington, a global law firm, has successfully advised MultiplAI Health Ltd. on its merger with OmnigenicsAI Corp. and APx...
